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Apoptosis induced by Magnolia Grandiflora 
extract in chlorambucil-resistant B-chronic 
lymphocytic leukemia cells
ABSTRACT
Background: B-cell chronic lymphocitic leukemia (B-CLL) still remains as an uncurable disease. Even the newest antineoplastic agents 
have demonstrated limitations in their efficacy. For this reason, further research of new compounds must be done. New pharmacological 
properties can be obtained from a great diversity botanical species. Among these products, Magnolia Grandiflora receives our attention 
since it mainly contains Honokiol which had demonstrated effect against B-CLL cells activating different cell death pathways. 
Aim: To test the ability of Magnolia Grandiflora extracts to induce apoptosis of B-CLL cells in vitro. 
Materials and Methods: Herb’s extraction: Twenty grams of powdered material were submitted to three consecutives decoctions 
with 500 ml of distilled water (96 ºC), filtered and followed by ultrafiltration with cellulose membrane, lyophilized and reconstituted 
in AIM-V medium at a final concentration of 10 mg/ml solution. B-CLL chlorambucil- resistant cells were separated and cultivated in 
the presence of Magnolia’s extract. Samples of cells were taken from the cultures at 24, 48 and 72 h for apoptosis analysis by flow 
cytometry measuring positive annexin V (0.1 µg/ml) cells. Statistics: Apoptosis values were represented by the mean plus or minus SD 
(± SD) for five independent experiments. Statistical significance was determined by Student’s t –test. A P value of 0.05 or less was 
considered as significant. 
Results and Conclusion: This article discusses the apoptosis properties of Magnolia on B-CLL cells. The evidence suggests a 
potentially effective repertoire for B-CLL treatment. This herb extract might have promising therapy strategies in treating B-CLL or other 
hematological disease resistant to alkylating agents in clinical practice. 
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INTRODUCTION
Diverse groups of botanical natural products have 
been described as the components of different 
Latin American Indians or Chinese traditional 
medicines.[1,2] Anti-tumor properties of many of 
these compounds have been recognized. Magnolia 
Grandiflora mainly contains Honokiol, Magnolol 
and Parthenolide which is a sesquiterpene 
lactone.[3] Honokiol and Magnolol are the major 
active constituents extracted from the bark of 
different Magnoliaceae species like Magnolia 
officinalis and Magnolia Grandiflora. They have 
a variety of pharmacological effects, such as 
anti-inflammatory,[4] antithrombotic,[5] anti-
arrhythmic,[6] antioxidant[7] and anxiolytic effects,[8] 
and more recently, cytotoxic activity by inducing 
cell apoptosis in some cell lines.[9] Magnolol 
and Honokiol-triggered apoptotic process is 
accompanied with down-modulation of Bcl-
XL molecules[10] or through Caspase cascades 
activation.[11] Parthenolide, a sesquiterpene lactone 
isolated from differents herbs (included Magnolia), 
is a novel NF-kappa B inhibitor[3] with interesting 
antineoplastic properties.[12-14] We previously had 
shown the anti tumor activity of Parthenolide 
in chronic lymphocitic leukemia (CLL) untreated 
model.[15] Since Parthenolide is a component of 
Magnolia, this herb might also have antineoplasic 
properties. 
The objective of this study has been to demonstrate 
Magnolia Grandiflora’s capacity to induce apoptosis 
in untreated B-cell chronic lymphocitic leukemia 
(B-CLL) cells and chlorambucil- resistant B-CLL 
cells model. 
MATERIALS AND METHODS
Herb’s extraction: Magnolia Grandiflora seed cones 
were collected, dried and grounded. Twenty grams 
of powdered material was extracted in a glass pot 
by three consecutives decoctions with 500 ml of 
distilled water at the sub-boiling point (96°C.) for 
50 min each, allowed to cool to room temperature, 
mixed, centrifuged and filtered though a microfilter 
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followed by ultrafiltration with a cellulose membrane. The 
ultrafiltrates were lyophilized and then reconstituted for the 
experiment in AIM-V medium at a final concentration of 10 
/CD23/CD19 in flow cytometry analysis (Coulter Epics XL). 
Cell Cultures: Leukemia cells either B-CLL or chlorambucil-
resistant B-CLL cells (ChR B-CLL cells-) were tested by seeding 
Magnolia’s extract in triplicate 2 ml cultures at a cell density 
of 2 × 105 cells per culture in 15 ml Falcon test tubes and three 
different Magnolia’s dilutions (1/300; 1/600 and 1/1200). The 
test tubes were incubated under standard conditions (37ºC, 
5% CO
2
 and 80% humidity). Incubation was continued for two 
days. Samples of cells were taken from the cultures at 24, 48 
and 72 h (by triplicate assays) for apoptosis analysis. 
Apoptosis analisis: The percentage of CD5-CD19 cells in 
apoptosis process was analyzed by flow cytometry measuring 
positive annexin V (0.1 μg/ml) cells (by tripicate). Results were 
expressed as the average values of these measurements. Same 
cells submitted only to media cultures (no Magnolia product 
in the culture) served as negative apoptotic controls. 
Statistics: Apoptosis values were represented by the mean 
plus or minus SD (± SD) for three independent experiments 
of each culture. Statistical significance was determined by 
Mann–Whitney non-parametric test. A P value of 0.05 or less 
was considered as significant. 
RESULTS
Aqueous Magnolia extract displayed apoptotic effect on 
untreated B-CLL cells and also heavy treated with chlorambucil 
B-CLL cells in vitro. 
Data shows that single 1/300 Magnolia`s extract dilution 
is active against chlorambucil- resistant B-CLL cells since 
these cells had very low viability after 24 h in Anexin-V flow 
cytometry tests .
When apoptosis process was measured, we found that 
Magnolia extract [Figure 1] at 1/300 dilution caused apoptosis 
in 58.4 ± 7.6% of the ChR B-CLL cells or 62.3 ± 5.2% non-
resistant B-CLL cells at 24 h [Figures 2 and 3] and 87.6 ± 4.1% 
or 84.9± 6.9% respectively at 48 h of culture with Magnolia’s 
extract at 1/300 dilution [Figure 1]. However, at 1/600 or 1/1200 
Magnolia’s dilution, the apoptosis was similar to control group 
(placebo’s extract) [Figure 1].< Figure 1>< Figure 2>< Figure 3>
Statistical significant differences were observed between ChR 
B-CLL or non-resistant B-CLL cells submitted to 1/300 dilution 
Magnolia’s extract, compared to either placebo or 1/600, 
1/1200 dilution extracts (P=0.001 in all cases). 
DISCUSSION 
Since large amount of research done on B-CLL during the past 
years has not changed at all its prognosis, new therapeutic 
pathways are needed in order to change this illness outcome. 
This work shows the potent apoptotic effect of Magnolia 
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Apoptosis of B-CLL cells and Chlorambucile resistant B-CLL cells at 24 and 48 hs with Magnolia’s extract at 
1/300; 1/600 and 1/1200 dilutions and Control placebo extract. 
Figure 2: Apoptosis at 24 hs in CHR B-CLL cells induced by Magnolia’s 
extract
 
Apoptosis is measured by flow Cytometry. 
Chlorambucil Non resisitant B-CLL were submitted 
to a 1/300 dilution of magnolia extract . Apoptosis 
was seen in 84.9% of the cells at 24 hs of 
exposured.
Figure 3: Apoptosis at 24 hs in non-resistant B-CLL cells induced by 
Magnolia’s extract
 
Apoptosis is measured by flow Cytometry. Non 
resistant  B-CLL were submitted to a 1/300 dilution 
of magnolia extract . Apoptosis was seen in 84.9% 
of the cells at 24 hs of exposured.
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Grandiflora on B-CLL cells that had demonstrated previous 
resistance to chorambucil treatment. 
Our results provide clues of potentially interacting pathways 
involving different aspects of B-CLL cell apoptosis that could 
be exploited in future therapies. In previous papers,[15] we had 
published that Magnolia’s extracts have efficacy in apoptosis 
and cytotoxicity induction and that these properties are 
exhibited mainly in tumors and not in normal cells, suggesting 
that an increase in NF-kappa B inhibitory protein and a 
decrease in NF-kappa B DNA binding activity or EGFR/PI3K/
Akt signaling pathway[16] or inhibition of telomerase activity 
might be involved in apoptosis induction.[17] 
The water extract of Magnolia Grandiflora had demonstrated 
in vitro activity against both non-resistant and chlorambucil-
resistant B-CLL cells suggesting that this family of herb’s 
extracts might have promising therapy strategies in treating 
B-CLL and other hematological diseases resistant to alkylating 
agents.
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